Cyclic nucleotide phosphodiesterase 3A-deficient mice as a model of female infertility.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Print ISSN: 0021-9738 (Print) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
    • Publication Information:
      Publication: 1999- : Ann Arbor, MI : American Society for Clinical Investigation
      Original Publication: New Haven [etc.] American Society for Clinical Investigation.
    • Subject Terms:
      Infertility, Female*/genetics; 3',5'-Cyclic-AMP Phosphodiesterases/*metabolism; 3',5'-Cyclic-AMP Phosphodiesterases/genetics ; Animals ; Cyclic AMP/metabolism ; Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors ; Cyclic AMP-Dependent Protein Kinases/metabolism ; Cyclic Nucleotide Phosphodiesterases, Type 3 ; Enzyme Inhibitors/metabolism ; Female ; Humans ; Isoenzymes/genetics ; Isoenzymes/metabolism ; Maturation-Promoting Factor/metabolism ; Meiosis/physiology ; Mesothelin ; Mice ; Mice, Inbred Strains ; Mice, Knockout ; Mitogen-Activated Protein Kinases/metabolism ; Oocytes/cytology ; Oocytes/physiology ; Ovary/anatomy & histology ; Ovary/physiology ; Ovulation/physiology ; Second Messenger Systems/physiology
    • Abstract:
      Since cAMP blocks meiotic maturation of mammalian and amphibian oocytes in vitro and cyclic nucleotide phosphodiesterase 3A (PDE3A) is primarily responsible for oocyte cAMP hydrolysis, we generated PDE3A-deficient mice by homologous recombination. The Pde3a(-/-) females were viable and ovulated a normal number of oocytes but were completely infertile, because ovulated oocytes were arrested at the germinal vesicle stage and, therefore, could not be fertilized. Pde3a(-/-) oocytes lacked cAMP-specific PDE activity, contained increased cAMP levels, and failed to undergo spontaneous maturation in vitro (up to 48 hours). Meiotic maturation in Pde3a(-/-) oocytes was restored by inhibiting protein kinase A (PKA) with adenosine-3',5'-cyclic monophosphorothioate, Rp-isomer (Rp-cAMPS) or by injection of protein kinase inhibitor peptide (PKI) or mRNA coding for phosphatase CDC25, which confirms that increased cAMP-PKA signaling is responsible for the meiotic blockade. Pde3a(-/-) oocytes that underwent germinal vesicle breakdown showed activation of MPF and MAPK, completed the first meiotic division extruding a polar body, and became competent for fertilization by spermatozoa. We believe that these findings provide the first genetic evidence indicating that resumption of meiosis in vivo and in vitro requires PDE3A activity. Pde3a(-/-) mice represent an in vivo model where meiotic maturation and ovulation are dissociated, which underscores inhibition of oocyte maturation as a potential strategy for contraception.
    • References:
      Mol Endocrinol. 1991 Dec;5(12):1939-46. (PMID: 1665204)
      Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6751-6. (PMID: 10841571)
      Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):8-10. (PMID: 11136241)
      J Biol Chem. 2003 Jul 4;278(27):24831-6. (PMID: 12709444)
      Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11998-2003. (PMID: 10518565)
      J Biol Chem. 2000 Apr 14;275(15):11348-54. (PMID: 10753948)
      Mol Endocrinol. 2002 Feb;16(2):331-41. (PMID: 11818504)
      Prog Nucleic Acid Res Mol Biol. 2001;66:241-77. (PMID: 11051766)
      Science. 2002 Oct 25;298(5594):834-6. (PMID: 12399592)
      Nat Genet. 2002 Apr;30(4):446-9. (PMID: 11912493)
      J Clin Invest. 1998 Sep 1;102(5):869-73. (PMID: 9727054)
      J Biol Chem. 2004 Apr 9;279(15):15214-22. (PMID: 14736883)
      Science. 2002 Aug 23;297(5585):1343-5. (PMID: 12193786)
      Proc Natl Acad Sci U S A. 2002 May 28;99(11):7628-33. (PMID: 12032334)
      J Biol Chem. 2002 Oct 11;277(41):38072-8. (PMID: 12154085)
      Development. 2000 Oct;127(19):4147-56. (PMID: 10976047)
      Dev Biol. 2003 Jun 15;258(2):385-96. (PMID: 12798295)
      J Biol Chem. 2002 Oct 4;277(40):37446-55. (PMID: 12169692)
      Biol Reprod. 2001 Nov;65(5):1444-51. (PMID: 11673261)
      Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3223-8. (PMID: 9096374)
      Prog Nucleic Acid Res Mol Biol. 2001;65:1-52. (PMID: 11008484)
      Methods Enzymol. 1988;159:457-70. (PMID: 2842611)
      J Clin Invest. 1998 Aug 1;102(3):532-7. (PMID: 9691090)
      J Clin Invest. 1995 Apr;95(4):1528-38. (PMID: 7706458)
      Mol Cell Endocrinol. 2002 Feb 22;187(1-2):153-9. (PMID: 11988323)
      J Clin Invest. 2002 Oct;110(7):1045-52. (PMID: 12370283)
      Mol Pharmacol. 1994 Sep;46(3):399-405. (PMID: 7935318)
      Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16794-9. (PMID: 12477927)
      Biol Reprod. 2002 Sep;67(3):981-7. (PMID: 12193411)
      Mol Cell Endocrinol. 2002 Jun 28;192(1-2):105-13. (PMID: 12088872)
      Dev Biol. 1996 Sep 15;178(2):393-402. (PMID: 8812137)
      Hum Reprod. 2002 Aug;17(8):2079-84. (PMID: 12151440)
      J Biol Chem. 2003 Feb 21;278(8):5493-6. (PMID: 12493749)
      Dev Biol. 1983 Jun;97(2):264-73. (PMID: 6189752)
      Biol Reprod. 1987 Apr;36(3):530-5. (PMID: 2885039)
      Biol Reprod. 1985 Oct;33(3):698-704. (PMID: 2996645)
      Biochem J. 2001 Jan 1;353(Pt 1):41-50. (PMID: 11115397)
      Mol Biol Cell. 2001 Jun;12(6):1791-9. (PMID: 11408585)
      Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4361-6. (PMID: 11904361)
      Biochem J. 2003 Jan 15;369(Pt 2):227-38. (PMID: 12374568)
      Curr Opin Cell Biol. 2000 Dec;12(6):666-75. (PMID: 11063930)
      Biol Reprod. 2003 Sep;69(3):1042-52. (PMID: 12773402)
      Biochem J. 2003 Feb 15;370(Pt 1):1-18. (PMID: 12444918)
      J Biol Chem. 1989 Jan 15;264(2):856-61. (PMID: 2463250)
      Mol Reprod Dev. 2003 Jul;65(3):336-43. (PMID: 12784256)
      Bioessays. 1991 Nov;13(11):569-74. (PMID: 1772412)
      Biol Reprod. 2001 Jul;65(1):188-96. (PMID: 11420239)
      Dev Biol. 1995 Nov;172(1):72-85. (PMID: 7589815)
      Mol Cell Endocrinol. 2002 Feb 22;187(1-2):161-71. (PMID: 11988324)
    • Grant Information:
      U54 HD031398 United States HD NICHD NIH HHS; U54-HD31398 United States HD NICHD NIH HHS
    • Accession Number:
      0 (Enzyme Inhibitors)
      0 (Isoenzymes)
      0 (Msln protein, mouse)
      E0399OZS9N (Cyclic AMP)
      EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases)
      EC 2.7.11.22 (Maturation-Promoting Factor)
      EC 2.7.11.24 (Mitogen-Activated Protein Kinases)
      EC 3.1.4.17 (3',5'-Cyclic-AMP Phosphodiesterases)
      EC 3.1.4.17 (Cyclic Nucleotide Phosphodiesterases, Type 3)
      EC 3.1.4.17 (PDE3A protein, human)
      EC 3.1.4.17 (Pde3a protein, mouse)
      J27WDC343N (Mesothelin)
    • Publication Date:
      Date Created: 20040716 Date Completed: 20040831 Latest Revision: 20240411
    • Publication Date:
      20240411
    • Accession Number:
      PMC449752
    • Accession Number:
      10.1172/JCI21804
    • Accession Number:
      15254586